首页> 外国专利> New positive allosteric Modulator of AMPA receptors (paarm), processes for their Preparation and their use as medicaments

New positive allosteric Modulator of AMPA receptors (paarm), processes for their Preparation and their use as medicaments

机译:AMPA受体(paarm)的新型正构构调节剂,其制备方法及其作为药物的用途

摘要

It refers to the Western Sahara modulator of new n-propane receptor in general formula (1), i.e., a refers to a sulfur atom, an oxygen atom, NH or n-tar C1-4; R1 refers to a radical modulator selected from group D and hydrogen group, In a group of C1-6 tar, one or more halogenated atoms and C1-6, C1-6, so-so2-tar, C1-6, C1-6, CO tar, or phenyl C1-4, c1-4-nr7r8 yalquil c1-4-o-c1-4, c1-4-tar or C3-6, R2, R9 or other substances are eventually replaced. They're radicals from the hydrogen groupThe C1-6 tar of deun formation is finally replaced by one or more halogenated atoms and halogenated carbon, NO2, so2h, so2-al quilo C1-6, so-c1-6, CO tar, C1-6, oh, or C1-6, c1-4-nr7-6, C1-4 - or C1-6 tar, or c1-o tar of c1-3-6; or un-r2 refers to a C1-6 bridge; R7, R8 are equivalent or different, signi can ignore C1-4 hydrogen or hydrocarbon; R3, R4, R5, R6 are equivalent or different, which means that in the group composed of hydrogen, a group of C1-6 tar (eventually replaced by one or more halogenated atoms) and a group of C1-4, halocarbon-4, C2, NO2, so2h, SO3H radionuclides,-SO2-C1-6 alkyl, -SO-C1-6 alkyl, -SO2-NR7R8, -COOH, -CO-C1-6 alkyl, -O-CO-C1-4 alkyl, -CO-O-C1-4 alkyl , -CO-NR7R8-C1-4 alkyl, -OH, -O-C1-6 alkyl, -S-C1-6 alkyl, -NR7R8 and an aryl radical optionally substituted once or multiple times with halogen atoms, -NO2, -SO2H or C1-4alkyl, possibly in the form of its different enantiomers and diastereoisomers, as well as their pharmacologically-acceptable salts. A procedures for its preparation as well as its use as medicines. Useful in dementia, neurodegenerative or psychotic diseases.
机译:它是指通式(1)中新的正丙烷受体的Western Sahara调节剂,即a是指硫原子,氧原子,NH或n-tar C1-4; R1是指选自D基团和氢基团的自由基调节剂。在C1-6焦油基团中,一个或多个卤原子和C1-6,C1-6,so-so2-焦油基,C1-6,C1-6基团最终将取代,CO焦油或苯基C1-4,c1-4-nr7r8 yalquil c1-4-o-c1-4,c1-4-tar或C3-6,R2,R9或其他物质。它们是氢基团.deun形成的C1-6焦油最终被一个或多个卤原子和卤化碳,NO2,so2h,so2-al quilo C1-6,so-c1-6,CO tar,C1取代-6,哦或C1-6,c1-4-nr7-6,C1-4-或C1-6焦油或c1-3-6的c1-o焦油;或un-r2表示C1-6桥; R 7,R 8是相同或不同的,可忽略C 1-4氢或烃; R 3,R 4,R 5,R 6是相同或不同的,这意味着在由氢组成的基团中,一组C 1-6焦油(最终被一个或多个卤原子取代)和一组C 1-4卤代碳-4 ,C2,NO2,so2h,SO3H放射性核素,-SO2-C1-6烷基,-SO-C1-6烷基,-SO2-NR7R8,-COOH,-CO-C1-6烷基,-O-CO-C1-4烷基,-CO-O-C1-4烷基,-CO-NR7R8-C1-4烷基,-OH,-O-C1-6烷基,-S-C1-6烷基,-NR7R8和任选取代一次的芳基或与卤素原子,-NO 2,-SO 2 H或C 1-4烷基多次结合,其形式可能是其不同的对映异构体和非对映异构体,以及它们的药理学上可接受的盐。制备及其用作药物的程序。在痴呆症,神经退行性疾病或精神病性疾病中有用。

著录项

  • 公开/公告号AR027352A1

    专利类型

  • 公开/公告日2003-03-26

    原文格式PDF

  • 申请/专利权人 BOEHRINGER INGELHEIM PHARMA KG;

    申请/专利号AR2001P100494

  • 发明设计人

    申请日2001-02-02

  • 分类号C07D513/06;A61K31/542;A61P25/00;

  • 国家 AR

  • 入库时间 2022-08-22 00:04:05

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号